// App-Quantinova.ai

6384 : TEAD inhibition reduces tumor proliferation in Merlin null meningioma and schwannoma

Researchers

Presenter

  • Liyam Laraba

Principal Investigators

  • Julio Grimm de Guibert

  • Tracy T. Tang

  • Leonard Post

  • David B. Parkinson

Medical Centers

  • University of Plymouth, Devon, United Kingdom

  • Vivace Therapeutics, San Mateo, CA

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Meningiomas

Biomarkers

  • Yes Associated Protein 1

Drug/Treatment

  • Manidipine+delapril

  • merlin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved